HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma (Q28236532)
Jump to navigation
Jump to search
scientific article (publication date: November 2007)
Language | Label | Description | Also known as |
---|---|---|---|
English | HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma |
scientific article (publication date: November 2007) |
Statements
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma (English)
0 references
1 November 2007
0 references
110
0 references
3310-5
0 references
9
0 references